VAXART, INC Debt to Equity Ratio 2011-2025 | VXRT

Current and historical debt to equity ratio values for VAXART, INC (VXRT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. VAXART, INC debt/equity for the three months ending September 30, 2025 was 0.00.
VAXART, INC Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-09-30 $0.18B $0.03B 6.81
2025-06-30 $0.13B $0.03B 3.99
2025-03-31 $0.11B $0.05B 2.48
2024-12-31 $0.11B $0.06B 1.82
2024-09-30 $0.10B $0.07B 1.44
2024-06-30 $0.03B $0.08B 0.42
2024-03-31 $0.03B $0.06B 0.59
2023-12-31 $0.03B $0.06B 0.59
2023-09-30 $0.03B $0.07B 0.48
2023-06-30 $0.04B $0.09B 0.44
2023-03-31 $0.04B $0.09B 0.45
2022-12-31 $0.04B $0.11B 0.39
2022-09-30 $0.05B $0.12B 0.43
2022-06-30 $0.04B $0.14B 0.27
2022-03-31 $0.03B $0.17B 0.20
2021-12-31 $0.03B $0.19B 0.18
2021-09-30 $0.04B $0.21B 0.18
2021-06-30 $0.03B $0.20B 0.15
2021-03-31 $0.03B $0.18B 0.17
2020-12-31 $0.03B $0.12B 0.24
2020-09-30 $0.02B $0.13B 0.18
2020-06-30 $0.02B $0.04B 0.60
2020-03-31 $0.02B $0.03B 0.68
2019-12-31 $0.02B $0.01B 1.86
2019-09-30 $0.02B $0.02B 1.26
2019-06-30 $0.02B $0.02B 1.35
2019-03-31 $0.02B $0.01B 1.89
2018-12-31 $0.02B $0.01B 2.14
2018-09-30 $0.03B $0.02B 1.54
2018-06-30 $0.03B $0.02B 1.14
2018-03-31 $0.03B $0.03B 0.82
2017-12-31 $0.04B $-0.04B -1.12
2017-09-30 $0.02B $0.01B 1.50
2017-06-30 $0.02B $0.02B 1.14
2017-03-31 $0.02B $0.02B 0.93
2016-12-31 $0.03B $0.03B 1.02
2016-09-30 $0.03B $0.04B 0.72
2016-06-30 $0.03B $0.05B 0.57
2016-03-31 $0.01B $0.05B 0.18
2015-12-31 $0.01B $0.06B 0.12
2015-09-30 $0.01B $0.06B 0.12
2015-06-30 $0.01B $0.07B 0.14
2015-03-31 $0.01B $0.08B 0.09
2014-12-31 $0.01B $0.08B 0.13
2014-09-30 $0.02B $0.08B 0.25
2014-06-30 $0.03B $0.09B 0.31
2014-03-31 $0.03B $0.10B 0.26
2013-12-31 $0.02B $0.06B 0.29
2013-09-30 $0.01B $0.07B 0.22
2013-06-30 $0.02B $0.07B 0.24
2013-03-31 $0.02B $0.08B 0.18
2012-12-31 $0.02B $0.08B 0.22
2012-09-30 $0.04B $0.03B 1.22
2012-06-30 $0.01B $0.06B 0.17
2012-03-31 $0.04B $0.06B 0.60
2011-12-31 $0.04B $0.06B 0.66
2011-09-30 $0.04B $0.06B 0.72
2011-06-30 $0.05B $0.06B 0.77
2011-03-31 $0.05B $0.06B 0.75
2010-12-31 $0.05B $0.06B 0.88
2010-09-30 $0.06B $0.07B 0.86
2010-06-30 $0.06B $0.07B 0.94
2010-03-31 $0.07B $0.09B 0.73
2009-12-31 $0.03B $0.10B 0.35
2009-09-30 $0.01B $0.10B 0.13
2009-06-30 $0.01B $0.11B 0.11
2009-03-31 $0.02B $0.12B 0.20
2008-12-31 $0.02B $0.12B 0.19
2008-09-30 $0.04B $0.12B 0.35
2008-06-30 $0.05B $0.13B 0.40
2008-03-31 $0.09B $0.13B 0.72
2007-12-31 $0.09B $0.15B 0.63
2007-09-30 $0.14B $0.08B 1.69
2007-06-30 $0.14B $0.10B 1.38
2007-03-31 $0.14B $0.10B 1.37
2006-12-31 $0.15B $0.11B 1.39
2006-09-30 $0.17B $0.11B 1.46
2006-06-30 $0.16B $0.13B 1.20
2006-03-31 $0.16B $0.14B 1.10
2005-12-31 $0.17B $0.16B 1.04
2005-09-30 $0.18B $0.24B 0.76
2005-06-30 $0.18B $0.25B 0.72
2005-03-31 $0.06B $0.27B 0.23
2004-12-31 $0.08B $0.28B 0.30
2004-09-30 $0.08B $0.30B 0.26
2004-06-30 $0.08B $0.31B 0.26
2004-03-31 $0.07B $0.32B 0.21
2003-12-31 $0.07B $0.32B 0.21
2003-09-30 $0.08B $0.23B 0.33
2003-06-30 $0.04B $0.19B 0.23
2003-03-31 $0.04B $0.19B 0.19
2002-12-31 $0.04B $0.19B 0.23
2002-09-30 $0.03B $0.19B 0.18
2002-06-30 $0.03B $0.19B 0.18
2002-03-31 $0.11B $0.19B 0.59
2001-12-31 $0.13B $0.19B 0.68
2001-09-30 $0.12B $0.18B 0.64
2001-06-30 $0.14B $0.08B 1.74
2001-03-31 $0.14B $0.08B 1.76
2000-12-31 $0.15B $0.08B 1.90
2000-09-30 $0.14B $0.07B 1.88
2000-06-30 $0.15B $0.07B 2.30
2000-03-31 $0.14B $0.06B 2.30
1999-12-31 $0.16B $0.06B 2.68
1999-09-30 $0.15B $0.06B 2.62
1999-06-30 $0.15B $0.05B 2.71
1999-03-31 $0.16B $0.05B 2.92
1998-12-31 $0.16B $0.05B 3.02
1998-09-30 $0.14B $0.07B 2.04
1998-06-30 $0.14B $0.07B 1.94
1998-03-31 $0.15B $0.07B 2.04
1997-12-31 $0.16B $0.08B 2.06
1997-09-30 $0.06B $0.08B 0.75
1997-06-30 $0.12B $0.09B 1.38
1997-03-31 $0.12B $0.09B 1.37
1996-12-31 $0.12B $0.09B 1.35
1996-09-30 $0.12B $0.08B 1.56
1996-06-30 $0.11B $0.07B 1.54
1996-03-31 $0.11B $0.07B 1.61
1995-12-31 $0.07B $0.07B 0.99
1995-09-30 $0.06B $0.06B 0.93
1995-06-30 $0.05B $0.06B 0.83
1995-03-31 $0.04B $0.06B 0.77
1994-12-31 $0.04B $0.05B 0.81
1994-09-30 $0.05B $0.03B 1.54
1994-06-30 $0.05B $0.03B 1.57
1994-03-31 $0.05B $0.03B 1.66
1993-12-31 $0.04B $0.02B 1.94
1993-09-30 $0.04B $0.02B 2.21
1993-06-30 $0.03B $0.02B 2.21
1993-03-31 $0.03B $0.02B 2.21
1992-12-31 $0.03B $0.01B 2.42
1992-09-30 $0.00B 0.00
1992-06-30 $0.03B $0.01B 2.72
1992-03-31 $0.03B $0.01B 2.84
1991-12-31 $0.01B $0.02B 0.76
1991-09-30 $0.01B $0.01B 0.92
1991-06-30 $0.01B $0.01B 0.62
1991-03-31 $0.01B $0.01B 0.71
1990-12-31 $0.01B $0.01B 0.96
1990-09-30 $0.01B $0.01B 1.26
1990-06-30 $0.01B $0.01B 1.23
1990-03-31 $0.01B $0.01B 1.33
1989-12-31 $0.02B $0.01B 1.51
1989-09-30 $0.01B $0.01B 1.50
1989-06-30 $0.01B $0.01B 1.43
1989-03-31 $0.01B $0.01B 1.61
1988-12-31 $0.01B $0.01B 1.49
1988-09-30 $0.01B $0.01B 1.53
1988-06-30 $0.01B $0.01B 0.85
1988-03-31 $0.01B $0.01B 0.80
1987-12-31 $0.01B $0.01B 0.68
1987-09-30 $0.01B $0.01B 0.76
1987-06-30 $0.01B $0.01B 0.67
1987-03-31 $0.01B $0.01B 0.70
1986-12-31 $0.01B $0.01B 1.16
1985-12-31 $0.01B $0.00B 2.55
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.089B $0.029B
Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $89.450B 33.97
Zoetis (ZTS) US $52.293B 18.72
Takeda Pharmaceutical (TAK) JP $45.598B 9.31
Daiichi Sankyo, - (DSNKY) JP $40.539B 20.19
BeOne Medicines - (ONC) CH $37.820B 185.50
Sandoz Group AG (SDZNY) CH $31.838B 0.00
United Therapeutics (UTHR) US $21.270B 18.72
Merck (MKKGY) DE $17.881B 11.02
Neurocrine Biosciences (NBIX) US $15.235B 36.56
Shionogi (SGIOY) JP $14.445B 13.27
Summit Therapeutics (SMMT) US $13.549B 0.00
Ionis Pharmaceuticals (IONS) US $13.091B 0.00
Madrigal Pharmaceuticals (MDGL) US $12.978B 0.00
IPSEN (IPSEY) FR $11.918B 0.00
Orion OYJ (ORINY) FI $9.738B 27.82
Corcept Therapeutics (CORT) US $9.256B 99.99
Eisai (ESAIY) $8.400B 0.00
Stevanato Group S.p.A (STVN) IT $6.305B 35.29
Grifols, S.A (GRFS) ES $6.284B 0.00
Ono Pharmaceutical (OPHLF) JP $6.238B 18.97
Crinetics Pharmaceuticals (CRNX) US $4.791B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $4.544B 0.00
NewAmsterdam Pharma (NAMS) NL $4.224B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $3.838B 18.22
Centessa Pharmaceuticals (CNTA) GB $3.564B 0.00
Ocular Therapeutix (OCUL) US $3.102B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.903B 9.26
Soleno Therapeutics (SLNO) US $2.793B 0.00
Dyne Therapeutics (DYN) US $2.752B 0.00
Hypermarcas (HYPMY) BR $2.737B 18.79
Aurinia Pharmaceuticals Inc (AUPH) CA $2.090B 24.77
Avadel Pharmaceuticals (AVDL) IE $2.086B 0.00
Guardian Pharmacy Services (GRDN) US $1.911B 36.81
Harrow (HROW) US $1.743B 106.96
BioCryst Pharmaceuticals (BCRX) US $1.594B 94.62
Collegium Pharmaceutical (COLL) US $1.537B 7.61
Ardelyx (ARDX) US $1.509B 0.00
Oruka Therapeutics (ORKA) US $1.461B 0.00
Amylyx Pharmaceuticals (AMLX) US $1.439B 0.00
Savara (SVRA) US $1.408B 0.00
Relay Therapeutics (RLAY) US $1.392B 0.00
Cronos Group (CRON) CA $1.250B 0.00
Xeris Biopharma Holdings (XERS) US $1.190B 0.00
Xencor (XNCR) US $1.180B 0.00
Nektar Therapeutics (NKTR) US $1.113B 0.00
Evotec AG (EVO) DE $1.069B 0.00
ARS Pharmaceuticals (SPRY) US $1.012B 0.00
Enliven Therapeutics (ELVN) US $1.001B 0.00
Theravance Biopharma (TBPH) US $0.921B 38.66
Esperion Therapeutics (ESPR) US $0.920B 0.00
KalVista Pharmaceuticals (KALV) US $0.855B 0.00
Aquestive Therapeutics (AQST) US $0.758B 0.00
Rigel Pharmaceuticals (RIGL) US $0.740B 6.61
Lyell Immunopharma (LYEL) US $0.732B 0.00
Lexeo Therapeutics (LXEO) US $0.713B 0.00
ProKidney (PROK) US $0.665B 0.00
Bioventus (BVS) US $0.625B 12.80
4D Molecular Therapeutics (FDMT) US $0.619B 0.00
Organogenesis (ORGO) US $0.612B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.582B 13.77
Altimmune (ALT) US $0.550B 0.00
Elite Pharmaceuticals (ELTP) US $0.537B 0.00
Zevra Therapeutics (ZVRA) US $0.469B 0.00
Siga Technologies (SIGA) US $0.463B 6.33
Akebia Therapeutics (AKBA) US $0.441B 0.00
Galectin Therapeutics (GALT) US $0.403B 0.00
Nature's Sunshine Products (NATR) US $0.398B 23.69
USANA Health Sciences (USNA) US $0.373B 10.42
Aclaris Therapeutics (ACRS) US $0.352B 0.00
Avalo Therapeutics (AVTX) US $0.337B 0.00
Larimar Therapeutics (LRMR) US $0.335B 0.00
OmniAb (OABI) US $0.310B 0.00
Fractyl Health (GUTS) US $0.307B 0.00
Silence Therapeutics (SLN) GB $0.299B 0.00
Relmada Therapeutics (RLMD) US $0.298B 0.00
Protara Therapeutics (TARA) US $0.294B 0.00
Aldeyra Therapeutics (ALDX) US $0.273B 0.00
Pyxis Oncology (PYXS) US $0.268B 0.00
Heron Therapeutics (HRTX) US $0.251B 0.00
Achieve Life Sciences (ACHV) CA $0.247B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.227B 0.00
Profound Medical (PROF) CA $0.221B 0.00
MediWound (MDWD) IL $0.211B 0.00
Surrozen (SRZN) US $0.211B 0.00
Journey Medical (DERM) US $0.208B 0.00
AleAnna (ANNA) US $0.196B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.170B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.164B 0.00
Innate Pharma SA (IPHYF) FR $0.160B 0.00
Gain Therapeutics (GANX) US $0.159B 0.00
Incannex Healthcare (IXHL) AU $0.146B 0.00
Cassava Sciences (SAVA) US $0.142B 0.00
Unicycive Therapeutics (UNCY) US $0.134B 0.00
Karyopharm Therapeutics (KPTI) US $0.119B 0.00
Inhibikase Therapeutics (IKT) US $0.116B 0.00
Prelude Therapeutics (PRLD) US $0.108B 0.00
Cardiol Therapeutics (CRDL) CA $0.107B 0.00
Avita Medical (RCEL) US $0.106B 0.00
Vivani Medical (VANI) US $0.098B 0.00
Context Therapeutics (CNTX) US $0.096B 0.00
Plus Therapeutics (PSTV) US $0.094B 0.00
Champions Oncology (CSBR) US $0.093B 33.60
Acrivon Therapeutics (ACRV) US $0.080B 0.00
Korro Bio (KRRO) US $0.078B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.077B 0.00
Rafael Holdings (RFL) US $0.076B 0.00
Verrica Pharmaceuticals (VRCA) US $0.075B 0.00
Assertio Holdings (ASRT) US $0.073B 0.00
Dominari Holdings (DOMH) US $0.071B 0.00
PMV Pharmaceuticals (PMVP) US $0.065B 0.00
Lite Strategy (LITS) US $0.063B 0.00
PolyPid (PYPD) IL $0.062B 0.00
Nutriband (NTRB) US $0.062B 0.00
Metagenomi (MGX) US $0.062B 0.00
Arch Biopartners (ACHFF) CA $0.061B 0.00
NRx Pharmaceuticals (NRXP) US $0.058B 0.00
Procaps Group, S.A (PROCF) LU $0.058B 0.00
BioNxt Solutions (BNXTF) CA $0.057B 0.00
Talphera (TLPH) US $0.055B 0.00
Wellgistics Health (WGRX) US $0.051B 0.00
Telomir Pharmaceuticals (TELO) US $0.050B 0.00
Century Therapeutics (IPSC) US $0.049B 0.00
Jupiter Neurosciences (JUNS) US $0.039B 0.00
ElectroCore (ECOR) US $0.038B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.038B 31.62
Mural Oncology (MURA) Ireland $0.035B 0.00
FibroGen (FGEN) US $0.034B 0.00
Klotho Neurosciences (KLTO) US $0.029B 0.00
SCYNEXIS (SCYX) US $0.027B 0.00
Inotiv (NOTV) US $0.026B 0.00
Vyome Holdings (HIND) US $0.026B 0.00
Scienture Holdings (SCNX) US $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.025B 0.00
Iterum Therapeutics (ITRM) IE $0.024B 0.00
Liminatus Pharma (LIMN) US $0.023B 0.00
Enlivex Therapeutics (ENLV) IL $0.023B 0.00
TherapeuticsMD (TXMD) US $0.020B 0.00
Natural Alternatives (NAII) US $0.019B 0.00
Citius Pharmaceuticals (CTXR) US $0.019B 0.00
Traws Pharma (TRAW) US $0.019B 0.02
Vivos Therapeutics (VVOS) US $0.019B 0.00
Lipocine (LPCN) US $0.018B 0.00
Mannatech (MTEX) US $0.016B 0.00
Mangoceuticals (MGRX) US $0.016B 0.00
Cosmos Health (COSM) US $0.015B 0.00
Tempest Therapeutics (TPST) US $0.015B 0.00
Heatwurx (PCSA) US $0.015B 0.00
BioLineRx (BLRX) IL $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.013B 0.00
VYNE Therapeutics (VYNE) US $0.013B 0.00
Phio Pharmaceuticals (PHIO) US $0.012B 0.00
Ainos (AIMD) US $0.011B 0.00
BioVie (BIVI) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
CASI Pharmaceuticals (CASI) CN $0.011B 0.00
Addex Therapeutics (ADXN) CH $0.010B 0.00
Alaunos Therapeutics (TCRT) US $0.010B 0.00
TransCode Therapeutics (RNAZ) US $0.009B 0.00
Quoin Pharmaceuticals (QNRX) US $0.009B 0.00
Aptorum Group (APM) GB $0.008B 0.00
Kiora Pharmaceuticals (KPRX) US $0.008B 0.00
Biomerica (BMRA) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.007B 0.00
Nuvilex (PMCB) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Xenetic Biosciences (XBIO) US $0.006B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
ProPhase Labs (PRPH) US $0.005B 0.00
Jaguar Animal Health (JAGX) US $0.005B 0.00
Salarius Pharmaceuticals (SLRX) US $0.005B 0.00
Indaptus Therapeutics (INDP) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.003B 0.00
CDT Equity (CDT) US $0.003B 0.00
Clearmind Medicine (CMND) CA $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
Aditxt (ADTX) US $0.002B 0.00
SciSparc (SPRC) IL $0.001B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
Indivior (INDV) US $0.000B 18.14
4D Pharma (LBPS) GB $0.000B 0.00
Minerva Neurosciences (NERV) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00